Companies · DD · Chemical (Specialty)
What does DuPont de Nemours' price assume?
The margin the price assumes
Revenue grows as its record suggests; the operating margin is solved at today's price.
At $155.61 on November 11, 2026, with revenue shrinking 5.0% a year, the price assumes an operating margin of 49.9% by year 5.
The price assumes
49.9%
Operating margin by year 5, solved at the price
Its 1-year median
−1.4%
Fiscal 2025–2025, adjusted for R&D and leases
Its industry
12.5%
Chemical (Specialty), Damodaran Online, January 2026
The price assumes a margin above the company's own median and above its industry's.
The numbers behind the chart
| Fiscal year | Adjusted operating margin |
|---|---|
| 2025 | −1.4% |
- Revenue growth, years 1 to 5
- −5.0% a yearFloored at −5%: revenue shrank faster than that over the record.SEC filings, revenue to fiscal 2025
- Margin path
- From today's margin to 49.9% by year 5Solved at the price. After that, the margin holds.
The growth the price assumes
At its median margin, no revenue growth between −50% and 100% a year matches today's price.
The assumptions both views share
These are neutral settings, the same for every company. Each view holds them and solves for one driver at today's price.
- Reinvestment
- $1.11 of revenue for each $1 investedThe industry's sales-to-capital ratio: how much new capital growth needs.Damodaran Online, January 2026 industry data, Chemical (Specialty)
- Cost of capital
- 8.06%The return investors need for the risk: the industry's beta, the market's risk premium, and debt rated B3/B- from its median margin, with a stated 5-year debt maturity. Built by the engine from the parts listed under Sources, each with its date.
- After year 10
- Growth at the riskfree rate, foreverNew investment earns its cost of capital and no more, so growth after year 10 adds no value, and the cost of capital moves to a mature company's.
Worth knowing
- It separated a business on November 3, 2025.
- Its ten-year record includes a business it has since separated, so older margins aren't fully comparable.
- The last twelve months' figures may still include the separated business: the filings don't restate them.
- Its filings report discontinued operations, so part of the record may be a business it no longer runs.
- Its adjusted record has 1 complete years, not ten.
- The growth used is a decline: the lower of its 5- and 10-year revenue rates is negative.
- Profitable in 7 of the last ten years, so its median margin is a weak yardstick.
- Its debt is large against its usual earnings: rated B3/B- at its median margin.
This is a mechanical starting point with neutral assumptions, not a valuation. The story decides.
Want to run your own story for DuPont de Nemours?
Join the waitlistSources
- Price: Qualuation's records, close of November 11, 2026.
- 10-K for the period ended December 31, 2025, filed February 17, 2026 (SEC EDGAR, accession 0001666700-26-000013).
- 10-Q for the period ended June 30, 2026, filed August 4, 2026 (SEC EDGAR, accession 0001666700-26-000053).
- Margin record: SEC filings, fiscal 2025-2025, operating margin adjusted for R&D and leases.
- Industry margin: Damodaran Online, January 2026 industry data, Chemical (Specialty), adjusted for R&D and leases.
- Sales to capital: Damodaran Online, January 2026 industry data, Chemical (Specialty).
- US 10-year Treasury yield (FRED), October 29, 2026.
- Less the US default spread (Damodaran Online, July 2026).
- Industry beta, Chemical (Specialty) (Damodaran Online, January 2026).
- Equity risk premium (Damodaran Online, October 2026).
- Debt rated B3/B- at its median margin (rating table, Damodaran Online, January 2026).
- The margin the price assumes: solved by the engine at the price on November 12, 2026, with the assumptions above.